These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 15893125

  • 1. Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome?
    Crentsil V.
    Med Hypotheses; 2005; 65(1):97-102. PubMed ID: 15893125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction.
    Akiho H, Deng Y, Blennerhassett P, Kanbayashi H, Collins SM.
    Gastroenterology; 2005 Jul; 129(1):131-41. PubMed ID: 16012943
    [Abstract] [Full Text] [Related]

  • 4. Treatment options in irritable bowel syndrome.
    Farthing MJ.
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):773-86. PubMed ID: 15324713
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors.
    Dinan TG, Clarke G, Quigley EM, Scott LV, Shanahan F, Cryan J, Cooney J, Keeling PW.
    Am J Gastroenterol; 2008 Oct; 103(10):2570-6. PubMed ID: 18785949
    [Abstract] [Full Text] [Related]

  • 7. [Postinfectious irritable bowel syndrome].
    Döbrönte Z, Lakner L, Sarang K.
    Orv Hetil; 2006 Oct 29; 147(43):2077-80. PubMed ID: 17297754
    [Abstract] [Full Text] [Related]

  • 8. Cyclic AMP signaling contributes to neural plasticity and hyperexcitability in AH sensory neurons following intestinal Trichinella spiralis-induced inflammation.
    Chen Z, Suntres Z, Palmer J, Guzman J, Javed A, Xue J, Yu JG, Cooke H, Awad H, Hassanain HH, Cardounel AJ, Christofi FL.
    Int J Parasitol; 2007 Jun 29; 37(7):743-61. PubMed ID: 17307183
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
    Jin Y, Ren X, Li G, Li Y, Zhang L, Wang H, Qian W, Hou X.
    J Gastroenterol Hepatol; 2018 Feb 29; 33(2):443-452. PubMed ID: 28573746
    [Abstract] [Full Text] [Related]

  • 13. Is irritable bowel syndrome a low-grade inflammatory bowel disease?
    Bercik P, Verdu EF, Collins SM.
    Gastroenterol Clin North Am; 2005 Jun 29; 34(2):235-45, vi-vii. PubMed ID: 15862932
    [Abstract] [Full Text] [Related]

  • 14. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?].
    Mearin F, Perelló A, Balboa A.
    Gastroenterol Hepatol; 2009 May 29; 32(5):364-72. PubMed ID: 19442413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. P2X7 receptor-dependent intestinal afferent hypersensitivity in a mouse model of postinfectious irritable bowel syndrome.
    Keating C, Pelegrin P, Martínez CM, Grundy D.
    J Immunol; 2011 Aug 01; 187(3):1467-74. PubMed ID: 21697458
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.